NEW YORKNEW YORK — Regulators in Brazil approved several versions of Angiotech Pharmaceuticals Inc.’s Quill suture product, the company said Thursday. Angiotech said the Quill SRS PDO, Monoderm, ...
The Quill (TM) SRS PDO is a longer-lasting absorbable suture, which istypically used for deeper tissue closures. Angiotech is now able to offer abroad range of PDO suture products with diameters ...
Shareholder group sues co for breach of merger agreement Shareholder group seeks punitive, other damages Former holders file demand with US arbitration group Oct 6 (Reuters) - Canada's Angiotech ...